RxDoctor Payments Data

Rachel Lehman

Family · Raleigh, NCNPI 1407938228

Payments from drug & device makers

$1,761in general payments, 2019–2025

Across 102 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$521
  • Lilly USA, LLC$194
  • Gilead$123
  • AstraZeneca$95
  • Boehringer Ingelheim$95
  • Abbott$87
  • plus $646 from 19 others

What the payments were for

  • Food & beverage$1,761100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,761 in reported general payments places this provider in the 80th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium29$183
Amlodipine Besylate31$151
Lisinopril16$132
Gabapentin16$109
Allopurinol13$52
Losartan Potassium16$51
Hydrochlorothiazide11$18

Paid to pharmacies, not to this prescriber.

Other family in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →